- Diagnostic Device
- Diagnostic Tests
Women’s Health Diagnostics Market size was valued at USD 26,712.3 million in 2023 and projected to reach USD 44,434.5 million by 2030 and poised to grow at 7.35% CAGR from 2024-2030. the increased prevalence of infectious disorders among women, such as hepatitis and urinary tract infections, is expected to fuel growth over the projection period. Advances in medical science provide lucrative chances to combat women-specific problems such as infectious illnesses, osteoporosis, and breast cancer.
Women’s Health Diagnostics Market Key Developments:
- In March 2023, The US FDA has authorized Visby Medical's sexual health test. It is a second-generation PCR test that employs self-collected vaginal swabs to diagnose STIs such as trichomoniasis, chlamydia, and gonorrhoea.
- In February 2023, Genetic Technologies Limited, a global leader in genomic-based diagnostics for health, wellness, and serious disease, has launched the 'World First' complete risk assessment test. This novel test assesses a woman's chance of acquiring breast and/or ovarian cancer due to either an inherited genetic mutation or the more frequent familial or sporadic malignancy.
Women’s Health Diagnostics Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
7.35%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Women’s Health Diagnostics Market Dynamics
The market is expected to grow rapidly due to the rising prevalence of chronic and lifestyle-related disorders, the growing number of imaging and diagnostic centres, the increased adoption of point-of-care and rapid diagnostic tests, as well as player collaborations and partnerships. The growing prevalence of diseases such as breast cancer, ovarian and cervical cancer, autoimmune diseases, and infertility among women need thorough diagnosis. Furthermore, rising stress levels among women are increasing the burden of numerous illnesses such as obesity, the danger of drug abuse, and increased alcohol consumption, all of which contribute to infertility. For example, data updated by the Census Bureau in April 2022 showed that fertility rates among women aged 20 to 24 fell by 43% in recent years, with only 66.59 births per 1,000 women in that age range, indicating a 42.79% fall in fertility over the previous decades. Furthermore, according to research released and amended by the National Institutes of Health in January 2023, nearly 11% of women of reproductive age in the United States, ranging from 18 to 35 years old, have encountered fertility issues in recent years. As the occurrence of infertility among women rises, so does the demand for fertility testing and diagnosis in emerging nations, which is expected to drive market expansion throughout the forecast period.
Women’s Health Diagnostics Market Segmentation
By Type
By Application
- Breast Cancer
- Infectious Disease
- Osteoporosis
- STD
- Other
Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The Women’s Health Diagnostics Market was valued at USD 26,712.3 million in 2023 and is projected to reach USD 44,434.5 million by 2030, growing at a CAGR of 7.56 %.
The market is expected to grow rapidly due to the rising prevalence of chronic and lifestyle-related disorders, the growing number of imaging and diagnostic centers, the increased adoption of point-of-care and rapid diagnostic tests, as well as player collaborations and partnerships.
Due to the rising incidence of breast cancer, demand for breast cancer tests is increasing in both emerging and developed countries, which is likely to drive segment growth over the forecast period.
Market research is segmented based on type, application, and region.
North America is estimated to dominate with the highest CAGR over the forecast period.
Key Features of the Reports
- The women’s health diagnostics market report provides granular level information about the Market size, regional Market share, historic Market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key Market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the Market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the Market.
- The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
| 1.Executive Summary |
| 2.Global Women’s Health Diagnostics Market Introduction |
| 2.1.Global Women’s Health Diagnostics Market - Taxonomy |
| 2.2.Global Women’s Health Diagnostics Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.Region |
| 3.Global Women’s Health Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Women’s Health Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Women’s Health Diagnostics Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Diagnostic Device |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Diagnostic Tests |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Women’s Health Diagnostics Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Breast Cancer |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Infectious Disease |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Osteoporosis |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. STD |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Other |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Women’s Health Diagnostics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Women’s Health Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Diagnostic Device |
| 8.1.2.Diagnostic Tests |
| 8.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Breast Cancer |
| 8.2.2.Infectious Disease |
| 8.2.3.Osteoporosis |
| 8.2.4.STD |
| 8.2.5.Other |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Women’s Health Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Diagnostic Device |
| 9.1.2.Diagnostic Tests |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Breast Cancer |
| 9.2.2.Infectious Disease |
| 9.2.3.Osteoporosis |
| 9.2.4.STD |
| 9.2.5.Other |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Women’s Health Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Diagnostic Device |
| 10.1.2.Diagnostic Tests |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Breast Cancer |
| 10.2.2.Infectious Disease |
| 10.2.3.Osteoporosis |
| 10.2.4.STD |
| 10.2.5.Other |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Women’s Health Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Diagnostic Device |
| 11.1.2.Diagnostic Tests |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Breast Cancer |
| 11.2.2.Infectious Disease |
| 11.2.3.Osteoporosis |
| 11.2.4.STD |
| 11.2.5.Other |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Women’s Health Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Diagnostic Device |
| 12.1.2.Diagnostic Tests |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Breast Cancer |
| 12.2.2.Infectious Disease |
| 12.2.3.Osteoporosis |
| 12.2.4.STD |
| 12.2.5.Other |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Abbott Laboratories |
| 13.2.2.GE Healthcare |
| 13.2.3.Mankind Pharma |
| 13.2.4.Quest Diagnostic Inc |
| 13.2.5.Siemens |
| 13.2.6.BD Company |
| 13.2.7.Hologic Inc |
| 13.2.8.Procter & Gamble Co |
| 13.2.9.Biome Rieux SA |
| 13.2.10.Koninklijke Philips NV |
| 13.2.11.Carestream Health |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Abbott Laboratories
- GE Healthcare
- Mankind Pharma
- Quest Diagnostic Inc
- Siemens
- BD Company
- Hologic Inc
- Procter & Gamble Co
- Biome Rieux SA
- Koninklijke Philips NV
- Carestream Health